Redx Pharma Past Earnings Performance

Past criteria checks 0/6

Redx Pharma's earnings have been declining at an average annual rate of -34.4%, while the Pharmaceuticals industry saw earnings growing at 9.7% annually. Revenues have been growing at an average rate of 38% per year.

Key information

-34.4%

Earnings growth rate

-13.0%

EPS growth rate

Pharmaceuticals Industry Growth7.3%
Revenue growth rate38.0%
Return on equity-988.3%
Net Margin-789.1%
Last Earnings Update30 Sep 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Redx Pharma makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:0RX Revenue, expenses and earnings (GBP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 234-33829
30 Jun 238-31930
31 Mar 2313-291032
31 Dec 2216-241030
30 Sep 2219-181029
30 Jun 2217-18928
31 Mar 2216-19827
31 Dec 2113-20726
30 Sep 2110-22624
30 Jun 218-20723
31 Mar 217-18821
31 Dec 206-14616
30 Sep 206-9410
30 Jun 205-8130
31 Mar 204-6100
31 Dec 194-5100
30 Sep 193-4100
30 Jun 192-5100
31 Mar 190-7110
31 Dec 180-8110
30 Sep 180-9110
30 Jun 1815-180
31 Mar 1831850
31 Dec 1731550
30 Sep 1730250
30 Jun 1715-9-10
31 Mar 170-19-70
31 Dec 160-17-30
30 Sep 160-1610
30 Jun 160-1480
31 Mar 160-12140
31 Dec 150-10130
30 Sep 150-8120
30 Jun 150-7110
31 Mar 150-5110
31 Dec 140-4110
30 Sep 140-3100

Quality Earnings: 0RX is currently unprofitable.

Growing Profit Margin: 0RX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 0RX is unprofitable, and losses have increased over the past 5 years at a rate of 34.4% per year.

Accelerating Growth: Unable to compare 0RX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 0RX is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (1.8%).


Return on Equity

High ROE: 0RX has a negative Return on Equity (-988.26%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies